Clinical trial Recruiting at 1 site Observational Ages 18 and up Women only

How the placenta affects maternal and fetal health

Official title: Placental Biology in Health and Disease

Run by University of Oxford · NCT07470320 · Data updated 2026-11-12

This project will test whether tiny particles released by the placenta differ in pregnancies with pre-eclampsia, gestational diabetes, or fetal growth restriction compared with healthy pregnancies and non-pregnant women.

Quick facts

Study typeObservational
Ages18 Years and up
SexWomen only
Enrollment1000 (estimated)
SponsorUniversity of Oxford
Academic / other
Locations1 site (Oxford)
StatusRecruiting
StartedDecember 16, 2025
Main results expectedMay 31, 2030
Study endsMay 31, 2030
Registry record updatedNovember 9, 2026
Trial IDNCT07470320 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include pregnant people with pre-eclampsia, gestational diabetes, fetal growth restriction, those at high risk for pre-eclampsia, healthy pregnant people, and healthy non-pregnant women willing to provide consent and samples at the Oxford site.

Probably not a fit

People whose pregnancy issues are caused by non-placental conditions or who cannot attend the single Oxford site are unlikely to benefit directly from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-site, non-interventional observational project collects blood and placental samples from pregnant people with pre-eclampsia, gestational diabetes, fetal growth restriction, predisposed pregnancies, healthy pregnancies, and non-pregnant controls. Laboratory analyses will focus on extracellular vesicles and soluble placental factors to characterize their number, contents, and signaling properties. Researchers will compare molecular signatures across groups to identify markers linked to placental dysfunction. The ultimate goals are to find biomarkers for earlier detection and molecular targets that could inform future treatments.

Why it matters

Potential benefit: If successful, the findings could enable earlier blood-based detection of placental problems and point to new targets for therapies that reduce maternal and fetal complications.

How similar studies have gone: Previous research has reported altered placental extracellular vesicles in pre-eclampsia and gestational diabetes, but translating those findings into clinical tests or treatments remains largely unproven.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Female, aged 18 years or above
* Willing and able to give informed consent for participation in the study
* Able to read and understand written and spoken English to comprehend study materials and give informed consent
* Non-pregnant women in good general health OR pregnant women who fall into one of the following:

  * Healthy pregnancy
  * Pre-eclampsia (PET) - defined by clinical diagnostic criteria, including hypertension and proteinuria
  * Gestational diabetes mellitus (GDM) - diagnosed by standard glucose tolerance tests during pregnancy
  * Fetal growth restriction (FGR) - diagnosed based on fetal weight or Doppler abnormalities
  * Predisposed to PET - high-risk factors for PET such as maternal type 1 or type 2 diabetes, autoimmune diseases or multiple pregnancies

Exclusion Criteria:

* Non-pregnant participants with active health conditions that could confound study outcomes
* Pregnant participants with conditions unrelated to PET, GDM or FGR that could influence EV profiles e.g. active infections or malignancies

Where it's running

  • Oxford University Hospitals NHS Foundation Trust
    Oxford, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.